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oxygen, cancer cells use glycolysis for energy
synthesis. In a process known as the Crabtree
effect, the glycolytic pathway is detached from the
citric acid (TCA) cycle (2). During glycolysis, a
single glucose molecule is converted to two
pyruvates. In healthy cells and under aerobic
conditions, pyruvate is oxidized to acetylcoenzyme A (acetyl-CoA), which may enter the
TCA cycle in the mitochondrial matrix. However,
cancer cells upregulate the enzyme lactate
dehydrogenase (LDH) [EC 1.1.1.27], which
produces lactate from pyruvate and regenerates
NAD for glycolysis (3). LDH alone is insufficient
to produce adequate amounts of the cofactor NAD
(3). The activity of cytosolic malate
dehydrogenase (MDH1) [EC 1.1.1.37] is also
necessary for NAD production (4). Cancer cells
overexpress both LDH and MDH1 to meet the
NAD demands for sustained glycolysis.
Upregulation of glycolysis in cancer cells
is further evidenced by the overexpression of key
glycolytic proteins, including
phosphofructokinase-1 (PFK1), glucose
transporters (GLUT), hexokinase II (HKII),
pyruvate dehydrogenase kinase (PDK), and
pyruvate kinase M2 (PKM2) (5). Activation of
these enzymes increases glucose migration into the
cell and enhances the glycolytic pathway,
ultimately contributing to tumorigenesis. Although
the evolutionary advantages of aerobic glycolysis
remain uncertain, it is probable that the glycolytic
pathway provides intermediates for other
metabolic pathways, including fatty acid synthesis
and the pentose phosphate pathway (PPP), serving
to increase the biomass of cancer cells (5). For
instance, glucose-6-phosphate (G6P), an
intermediate molecule in the glycolytic pathway,
can be oxidized to 6-phosphoglucono-lactone,
which can then enter other metabolic pathways,

Cancer cells preferentially undergo glycolysis in
aerobic environments, a phenomenon termed
the Warburg effect. Malate dehydrogenase
(MDH) catalyzes the reversible interconversion
of malate and oxaloacetate. Human cytosolic
malate dehydrogenase (hMDH1) isoform 3 is
involved in the malate-aspartate shuttle (MAS),
which oxidizes cytosolic NADH. hMDH1 is
implicated in high aerobic glycolysis in cancer
cells because NAD is a necessary cofactor for
glycolysis. Thus, hMDH1 is a promising
molecular target for cancer treatment. A single
proline residue at position 110 in the mobile
active site loop of hMDH1 was mutated to a
serine with the intention of altering the
enzyme’s substrate specificity. Steady-state
kinetics analysis showed that mutant activity
with the native substrate, oxaloacetate,
exceeded that of the wildtype (WT) enzyme (kcat
of 320 ± 10 s-1 and 780 ± 30 s-1 for the WT and
mutant, respectively). Catalytic activity of both
enzymes decreased significantly with the
alternative substrate, α-ketoglutarate (kcat of 3 ±
{6} s-1 and 0.19 ± 0.01 s-1 for the WT and
mutant, respectively). The specificity constant
(ksp = kcat /KM) signifies the efficiency of an
enzyme for competing substrates. The ksp values
for the WT and mutant with OAA were 1.7 ±
0.2 × 107 M-1s-1 and 8.21 ± 0.46 × 106 M-1s-1,
respectively. These ksp values were substantially
higher than those for both enzymes with αketoglutarate. We can conclude that the WT
and mutant hMDH1 enzymes function
optimally with oxaloacetate. Also, Pro110Ser
hMDH1 has altered substrate specificity, with
α-ketoglutarate functioning as an alternative
substrate.
Warburg metabolism is a hallmark of
cancer cells (1). Even in the presence of sufficient
1
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including the PPP. Growing evidence also suggests drive the reversible interconversion of malate and
that increased glycolysis correspondingly increases oxaloacetate (OAA). Once the substrate binds, the
the rate of ATP synthesis, which is advantageous
loop closes, and catalysis begins. Evaluation of the
for cancer cell proliferation (5).
loop revealed a rigid proline amino acid residue at
While the role of LDH in NAD production position 110 (Fig. 2A). Mutation numbering is
is well established, that of hMDH1 is more
based on the protein produced by the plasmid. In
ambiguous. Distinct isoforms of MDH differ in
order to enhance the flexibility of the loop, a serine
their subcellular localizations. hMDH1 is
residue was introduced at position 110 (Fig. 2B).
implicated in the malate-aspartate shuttle (MAS),
The mutagenesis tool in PyMOL was used for this
which carries electrons from the cytosol into the
purpose.
mitochondrial matrix through malate (4). Thus,
MAS transports equivalents from cytosolic NADH
Lys-118
into the mitochondria (6). This shuttle system
Glu-116
Leu-121
Lys-122
ultimately regenerates NAD in the cytosol, which
is again necessary for continued glycolysis.
Reducing or manipulating hMDH1 activity may
serve as a potential treatment for cancer.
Leu-120
Met-115
Here we report the results of the
Met-109
production, purification, and characterization of a
Ser-108
novel mutant hMDH1 protein. Kinetics analysis
Malate
suggests that the mutant enzyme is more active
than the WT with the endogenous oxaloacetate
Arg-111
Pro-110
(OAA) substrate, as it has a higher turnover
number (kcat). The WT enzyme has greater
proficiency with OAA than does the mutant,
Glu-113
NAD
suggested by the higher specificity constant (ksp) of
Arg-112
the WT. Both the WT and the mutant are
significantly less active with the alternative
Figure 1. PyMOL generated visual of MDH1 loop. This
substrate, α-ketoglutarate (AKG), a key molecule
image displays the residues situated in the mobile
in the Krebs cycle. However, the mutant enzyme is
likely more active and proficient with AKG,
active site loop of MDH1 [PDB: 5MDH]. Porcine MDH
relative to the WT. Together, this information
was used as a model for the human enzyme. The loop
suggests that residue Pro-110 within the active site
closes around its substrate and orients it in the correct
loop of hMDH1 is a potential candidate for altered
position for productive catalysis. Loop residues are
catalytic activity and substrate specificity of this
shown in purple. Malate is featured in the back of the
enzyme.
image. The oxidized cofactor, NAD, is shown as well.
Results
WT plasmid DNA purification
hMDH1 isoform 3 pET28a plasmid DNA
Mutation selection within the active site loop
was
extracted
from Escherichia coli (E. coli)
Since there is no solved structure of the
BL21(DE3) cells and analyzed using a
human cytosolic malate dehydrogenase 1
microvolume spectrophotometer. The 260/280 and
(hMDH1) enzyme [P40925-3], a model structure
based on the porcine MDH enzyme [PDB: 5MDH] 260/230 ratios indicate nucleic acid purity. The
A260/A280 ratio was 1.90, which falls within the 1.8was analyzed. PyMOL Molecular Graphics
2.0 range that is generally accepted as “pure” for
Service System (7) was used to visualize the
DNA (Fig. 3). This suggests the absence of protein
mobile loop that bends into the active site of the
enzyme (Fig. 1). Catalytic residues within this loop in the DNA sample and that it is pure. Expected
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Figure 2. PyMOL generated image of proline to serine mutation. (A) The proline residue at position
110 in the mobile active site loop of hMDH1 was replaced with a serine. Proximity of Pro-110 with
the substrate, malate, and cofactor, NAD, is featured here. (B) The smaller serine amino acid residue
was introduced to confer flexibility to the loop.
260/230 values for nucleic acids are commonly in
the range of 2.0-2.2. The 260/230 ratio was 1.93,
which is only moderately lower than the accepted
value for pure DNA. The low ratio is reflected in
the high troughs on the graph plotting absorbance
versus wavelength in nm. Finally, the DNA
concentration was relatively high at 157.6 ng/µL.

pET28a plasmid. The restriction enzymes XhoI
and ClaI digested the plasmid DNA for about 30
minutes. The digest was expected to produce two
distinct DNA fragments at 4.9 kb and 1.4 kb,
respectively. These were the expected fragment
sizes based on bioinformatics work in Benchling.
Gel electrophoresis analysis revealed a single,
bright band and a faint band of cut DNA (Fig. 4,
lane 2).

Restriction enzymes
A double restriction analysis (Fig. 4) was
performed to verify the existence of the WT
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Figure 3. WT hMDH1 plasmid DNA data. Once the WT hMDH1 isoform 3 pET28 plasmid DNA was
extracted from E. coli BL21(DE3) cells, the concentration was determined using a microvolume
spectrophotometer. The DNA concentration was 157.6 ng/µL.

Figure 4. Restriction enzyme analysis. A double restriction digest was performed on the WT hMDH1
isoform 3 pET28a plasmid DNA with the restriction enzymes XhoI and ClaI. Lane 1 depicts the ladder and
lane 2 features the cut WT plasmid DNA. Two distinct bands are shown in lane 2.
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Figure 5. Putative hMDH1 mutant plasmid DNA data. Once the potential mutant hMDH1 isoform 3 pET28
plasmid DNA was extracted, the concentration was determined with a microvolume spectrophotometer.
The DNA concentration was 72.1 ng/µL.
Site-directed mutagenesis and transformation of
competent E. coli cells
After the presence of the WT pET28a
plasmid was verified via restriction analysis, sitedirected mutagenesis was employed to produce the
Pro110Ser mutation. Polymerase Chain Reaction
(PCR) was performed on the WT plasmid to
introduce three new nucleotides at position 110 in
the gene encoding hMDH1. The correct size of the
fragment (6.292 kilobases) was confirmed with gel
electrophoresis. A kinase, ligase, and Dpnl (KLD)
treatment was used to recircularize the plasmid.
Competent NEB 5a E. coli cells were next
transformed with the putative mutant plasmid. The
transformants are potential bacterial colonies that
took up the putative mutant hMDH1 plasmid (Fig.
6).

Figure 6. Transformation of 5α E. coli cells. Following
PCR to introduce a substitution mutation (Pro110Ser)
into the WT hMDH1 plasmid, a kinase, ligase, and Dpnl
(KLD) treatment was performed to recircularize the
putative mutant hMDH1 isoform 3 pET28a plasmid. A
transformation was completed to introduce the
putative mutant hMDH1 plasmid into competent NEB
5α E. coli cells.

Mutant plasmid DNA purification
The putative mutant plasmid DNA
extracted from BL21(DE3) cells was pure. The
DNA concentration was relatively high at 72.1
ng/µL. The 260/280 and 260/230 ratios (Fig. 5)
indicate nucleic acid purity. The A /A ratio was
260

280
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1.91, which falls within the recommended 1.8-2.0
range for “pure” DNA. Expected 260/230 values
for nucleic acids are commonly in the range of 2.02.2. The 260/230 ratio was 1.75, which was lower
than that accepted for pure DNA. The low ratio is
reflected in the high troughs on the graph plotting
absorbance versus wavelength in nm. The putative
mutant plasmid DNA may contain some
contaminants.

colonies that took up the mutant hMDH1 plasmid
(Fig. 7). The transformation efficiency, defined as
the number of transformants per unit mass of DNA
on the plate, was 1.7 × 103 transformants/µg.
Protein overexpression, cell lysis, and purification
Transformation of Xjb (DE3) cells was
followed by overexpression, in which the plasmid
gene was used by the host bacterium to transcribe
mRNA, followed by translation into protein. Both
the WT plasmid and the plasmid encoding the gene
for the genetically modified hMDH1 mutant
plasmid DNA were overexpressed. Cells
overexpressing the WT hMDH1 isoform 3 protein
and the mutant protein were lysed to obtain a
lysate that could be used to purify the protein by
nickel affinity (Ni-NTA) chromatography. Both
the WT and the mutant proteins eluted at an
imidazole concentration of 250 mM in the
chromatography experiment.

Mutant plasmid confirmation
The putative mutant plasmid DNA
extracted from BL21(DE3) cells was sent to
GeneWiz for sequencing. The sequencing results
revealed the correct substitution of three
nucleotides (CCA), which encode proline, with
three different nucleotides (AGC), which encode
serine at position 110 in the hMDH1 isoform 3
gene.

BCA assay on WT and mutant hMDH1
A bicinchoninic (BCA) assay was performed
to determine the concentration of the WT and the
mutant hMDH1 enzymes. The BCA standard
solutions were used to construct a standard curve
(Fig. 8). The concentrations of the WT and mutant
proteins were determined from the standard curve
(0.334 mg/mL and 0.44 ± 0.02 mg/mL,
respectively).
SDS-PAGE analysis of WT and mutant hMDH1
proteins
SDS-PAGE was used to determine the
molecular weights of the WT and mutant hMDH1
proteins. The molecular weights of the protein
bands were determined by constructing a standard
curve of the square root of the molecular weight of
the ladder proteins versus the log of the distance
each ladder protein band travelled from the top of
the gel (Fig. 10). Distances were measured in
centimeters. The resulting linear regression
equation was used to determine the molecular
weights of the proteins in the gel bands. Two

Figure 7. Bacterial transformation of XJb (DE3)
cells. The plasmid encoding the gene for the
genetically modified hMDH1 isoform 3 was
introduced into XJb (DE3) bacterial cells.
Transformation of competent E. coli cells
The plasmid encoding the gene for the
genetically modified hMDH1 mutant plasmid
DNA was introduced into Xjb (DE3) Autolysis
cells. Transformants on the plate are potential
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Figure 8. BCA assay for determining wildtype and mutant protein concentration. The absorbance
measurements of a series of standard solutions of BCA were plotted against concentration to yield a
linear standard curve. The concentration of the WT hMDH1 protein was determined to be 0.334
mg/mL, while that of the mutant was determined to be 0.44 ± 0.02 mg/mL.
prominent dark blue bands appeared on the gel,
one for the mutant enzyme (Fig. 9, lane 2) and one
for the WT enzyme (Fig 9, lane 3). The calculated
molecular weight of the mutant protein was 34.8
kDa, whereas that of the WT protein was 39.4
kDa. These values match well with the expected
molecular weights, confirming the presence of the
purified proteins.

Square Root of Mwt (kDa1/2)

14.00
12.00

y = -13.732x + 17.179
R² = 0.9818

10.00
8.00
6.00
4.00
2.00
0.200

0.400

0.600

0.800

1.000

1.200

Log of Distance Migrated (cm)

Figure 9. Protein analysis by SDS-PAGE.
SDS-PAGE was used to determine the
molecular weights of the WT and mutant
hMDH1 proteins. SDS-PAGE also verified
the success of the purification procedure.
A sharp band occured at approximately 37
kDa for both the mutant (lane 2) and the
WT (lane 3) samples.

Figure 10. SDS-PAGE standard curve. A standard curve
plotting square root of molecule weight of the ladder
proteins as a function of the logarithm of the distance
migrated by the ladder proteins was created. The
molecular weights of the WT and mutant hMDH1 proteins
were determined from the best-fit equation for the data.
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Table 1
Steady-state kinetic parameters for WT hMDH1 with different substrates
Substrate

Kcat (s-1)

Ksp (M-1s-1)

KM (µM)

OAA

320 ± 10

17 ± 2

AKG

3 ± {6}

0.003 ±
{0.008}

18.4 ± 0.1

t-Statistic
(Kcat)
25.8799

t-Statistic
(Ksp)
8.51959

{1,098} ± 3

0.556613

0.360203

P-Value
(Kcat)
5.33277 ×
10-9
0.607462

P-Value
(Ksp)
2.76856 ×
10-5
0.736909

Table 2
Steady-state kinetic parameters for mutant hMDH1 with different substrates
Substrate

Kcat (s-1)

Ksp (M-1s-1)

KM (µM)

OAA

780 ± 30

8.21 ± 0.46

AKG

0.19 ±
0.01

0.00029 ±
0.00003

95.33 ±
0.07
{666.2} ±
0.1

t-Statistic
(Kcat)
25.5726

t-Statistic
(Ksp)
17.8344

19.1259

9.21413

P-Value
(Kcat)
5.86153 ×
10-9
3.12139 ×
10-4

P-Value (Ksp)
1.0007 × 10-7
0.00270391

B

A

C

D

Figure 11. Mathematica plots for WT and mutant with OAA and AKG. Kinetics parameters were evaluated for
the WT and the mutant enzyme in the presence of the native substrate, oxaloacetate (OAA), and an alternative
substrate, α-ketoglutarate (AKG). (A) WT enzyme activity was evaluated with OAA. The data was fitted to a nonlinear model. (B) Mutant hMDH1 enzyme activity was monitored with OAA. (C) The WT enzyme was treated
with AKG, but the data was difficult to fit to a curve. (D) The mutant enzyme was treated with AKG.
8

Altered Substrate Specificity via Pro110Ser Mutation
Steady-state kinetics
The activities of both the WT and mutant
hMDH1 were evaluated under steady-state
conditions. The results show a kcat of 320 ± 10 s-1
for the WT enzyme with the native substrate, OAA
(Table 1). kcat for the mutant enzyme with OAA
(780 ± 30 s-1) was roughly double that for the WT
(Table 2). The KM for the WT enzyme with OAA
was 18.4 ± 0.1 µM, and the ksp was 1.7 ± 2 × 107
M-1s-1 (Table 1). The KM for the mutant enzyme
with OAA was much higher at 95.33 ± 0.07 µM,
and the ksp was roughly half that of the WT, at 8.21
± 0.46 ×106 M-1s-1 (Table 2). Enzyme activity and
proficiency were studied with an alternative
substrate, AKG. The kcat of the WT enzyme with
AKG was 3 ± {6} s-1 (Table 1). The KM for the WT
enzyme with AKG was {1,098} ± 3 µM, and the
ksp is 0.003 ± {0.008} × 106 M-1s-1 (Table 1). By
contrast, the kcat of the mutant enzyme with AKG
was 0.19 ± 0.01 s-1 (Table 2). The KM for the
mutant enzyme with AKG was {666.2} ± 0.1 µM,
and the ksp was 0.00028 ± 0.00003 × 106 M-1s-1
(Table 2). The kinetic data were fitted using the
online version of Wolfram Mathematica (8) to
obtain the kinetic parameters (Fig. 11A, B, C, D).

numbering is based on the protein produced by the
plasmid, which contains an N-terminal glycine.
Proline is arguably the most rigid amino acid
residue, since its side chain is connected to the
protein backbone twice. Serine, on the other hand,
is more flexible because it lacks a ring, and its side
chain is relatively small. Replacing a rigid,
moderately bulky side chain with a smaller side
chain was hypothesized to increase the flexibility
of the loop, allowing it to accommodate longer
substrates like AKG. Serine was chosen with the
intention of introducing hydrogen bonding
contacts in the active site, which might contribute
to transition state stabilization in the conversion
from substrate to product. However, no polar
contacts were formed, likely because serine was
situated too far from other residues in the loop
(Fig. 2B).
WT hMDH1 isoform 3 pET28a plasmid
DNA was extracted from E. coli BL21(DE3) cells.
The WT plasmid was purified and analyzed using
a microvolume spectrophotometer (Fig. 3). The
260/280 and 260/230 ratios were assessed to
determine nucleic acid purity. The 260/280 ratio
was 1.90, which falls within the expected range for
“pure” DNA (1.8-2.0). The proper ratio suggests
the absence of protein in the DNA sample and that
it is pure. A 260/280 ratio of about 2.0 is generally
accepted as “pure” for RNA. Since the ratio is
slightly higher than 1.8, the DNA might contain a
small amount of RNA. Expected 260/230 values
for nucleic acids are commonly in the range of 2.02.2. The 260/230 ratio was 1.93, which is slightly
lower than the accepted value for pure DNA. The
high troughs on the graph plotting absorbance
versus wavelength in nm reflect this low ratio. The
WT plasmid DNA may contain some
contaminants, such as genomic DNA. Perhaps the
cells were subjected to mechanical stress during
the extraction experiment. Finally, the DNA yield
was relatively high at 157.6 ng/µL.
The double restriction digest results verify
the presence of the WT pET28a plasmid DNA and
suggest that it is of high quality and concentration.
The restriction enzymes XhoI and ClaI were used
to fragment the plasmid DNA. XhoI recognizes the
DNA sequence C/TCGAG. The DNA recognition
sequence for ClaI is AT/CGAT. The first band of

Discussion
Site-directed mutagenesis was employed to
construct a plasmid containing a mutant hMDH1
gene and to evaluate the role of conformational
flexibility of the active site loop. Enhanced
mobility of the loop was predicted to permit larger
substrates, like α-ketoglutarate (AKG), to fit into
the binding pocket. The PyMOL images of the
mobile active site loop of hMDH1 display a
diverse range of residues, which likely influence
the flexibility of the loop and its catalytic
properties (Fig. 1). Residues in the loop region are
conserved across taxa, but not all residues are
essential for catalysis (9). Residues, like active site
arginines, that are critical for substrate orientation
and enzyme reactivity were likely poor candidates
for mutagenesis. With the intention of altering
substrate recognition, the proline amino acid
residue located at position 110 of the hMDH1 gene
was replaced with a serine. Note that the mutation
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cut DNA (Fig. 4, lane 2) is sharp and bright,
whereas the second band of cut DNA (Fig. 4, lane
2) is slightly fainter. The faint DNA band is likely
a consequence of the difficulty of visualizing
smaller fragments on a gel. The bands appear at
the expected fragment sizes of 4.9 kb and 1.4 kb,
determined from the bioinformatics platform,
Benchling (10). These results suggest that the WT
hMDH1 plasmid was successfully amplified.
Site-directed mutagenesis of the WT
pET28a plasmid was next performed. PCR was
used to amplify the plasmid DNA and introduce
the Pro110Ser mutation. The PCR results suggest
that mutagenesis was successful, as a band
appeared at the correct fragment size of 6.292
kilobases. The putative mutant hMDH1 isoform 3
pET28a plasmid was recircularized with a KLD
treatment. Finally, competent NEB 5α E. coli cells
were transformed with the putative mutant
hMDH1 plasmid (Fig. 6). Many small colonies
appear on the plate, suggesting that the
transformation was successful.
To eventually verify the presence of the
desired mutation, the putative mutant plasmid
DNA was extracted and purified from BL21(DE3)
cells. The DNA concentration was relatively high
at 72.1 ng/µL (Fig. 5). The 260/280 and 260/230
ratios indicate plasmid purity. The A260/ A280 ratio
falls within the recommended range (1.8-2.0) for
“pure” DNA, at 1.91. This indicates the absence of
protein in the DNA sample and that it is pure.
However, because the ratio is slightly higher than
1.8, the DNA might have a small amount of RNA
in it. A high 260/280 ratio is not usually indicative
of a problem, however. Expected 260/230 values
for nucleic acids are commonly in the range of 2.02.2. The 260/230 ratio was 1.75, which is lower
than that accepted for pure DNA. The low ratio is
reflected in the high troughs on the graph plotting
absorbance versus wavelength in nm. The putative
mutant plasmid DNA may contain some
contaminants including genomic DNA.
The putative mutant plasmid DNA
extracted from BL21(DE3) cells was sent to
GeneWiz for sequencing. The sequencing results
indicate the correct substitution of three
nucleotides (CCA), which encode proline, with
three alternative nucleotides (AGC), which encode

serine, at position 110 in the hMDH1 isoform 3
gene. The plasmid encoding the gene for the
genetically modified hMDH1 isoform 3 was next
introduced into XJb (DE3) bacterial cells. These
cells are designed to take up protein efficiently.
Small colonies on the plate suggest that the
bacteria successfully took up the mutant plasmid
(Fig. 7). However, small “satellite” colonies that
grew where kanamycin had been broken down by
the larger antibiotic-resistant transformed colonies
appeared on the plate. The satellite colonies were
non-transformed cells that surrounded larger
transformed colonies. These satellite colonies were
not included in the determination of transformation
efficiency, nor were they used in future culture
inoculation. The transformation efficiency was
1.7 × 103 transformants/µg, which lies just outside
of the expected range of 104-107 transformants/µg.
Transformation of XJb (DE3) autolysis
cells was followed by overexpression of the
mutant hMDH1 isoform 3 protein. Cells
overexpressing the mutant protein were isolated as
a cell lysate. The lysate was purified by Ni-NTA
chromatography. The same overexpression, lysis,
and purification sequence was performed for the
WT hMDH1 enzyme. Protein concentrations were
determined by the Bicinchoninic (BCA) assay,
which uses a standard curve of BCA standard
solutions (Fig. 8). The correlation coefficient of
the standard curve was high at 0.989, indicating
that a linear fit was appropriate for the data. The
mutant protein concentration was 0.44 ± 0.02
mg/mL. The WT protein concentration was lower
at 0.334 mg/mL. The standard deviation for the
mutant hMDH1 concentration was low at 0.02
mg/mL, suggesting that the concentration was
determined precisely from the BCA standard
curve.
The SDS-PAGE results suggest that the
WT and the mutant hMDH1 proteins were
successfully purified. A single, dark band exists
for both enzymes at approximately 37 kDa (Fig.
9). Upward curving of the protein bands on both
sides of the gel was likely caused by uneven
temperature over the whole gel. The calculated
molecular weight for the WT protein was 39.4
kDa, whereas that for the mutant was 34.8 kDa.
The exact molecular weights of the WT and
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kcat of the WT enzyme with AKG was 3 ± {6} s-1
(Table 1). The KM for the WT enzyme with AKG
was {1,098} ± 3 µM, and the ksp was 0.003 ±
{0.008} × 106 M-1s-1. By contrast, the kcat of the
mutant enzyme with AKG was 0.19 ± 0.01 s-1
(Table 2). The KM for the mutant enzyme with
AKG was {666.2} ± 0.1 µM, and the ksp was
0.00028 ± 0.00003 × 106 M-1s-1. Catalytic activity
of both enzymes is substantially lowered with the
alternative substrate. However, the unreasonably
high errors in kcat and ksp for the WT enzyme
suggest that the data is not a good fit (Table 1).
The measurements for kcat, ksp, and KM for the WT
are unreliable. Likewise, the plot of Kobs versus
concentration of AKG did not yield the expected
curve (Fig. 11C). The magnitude of the decrease in
kcat with AKG for the WT enzyme was
significantly less than expected, supporting the
conclusion that the data is essentially erroneous
(14). The mutant with AKG data, on the other
hand, has relatively well determined constants,
suggesting that the mutant is more effective on
AKG than is the WT (Table 2). The non-linear
curve fit was also appropriate for the mutant with
AKG (Fig. 11D). As predicted, the smaller side
chain of serine likely expanded the region for
substrate binding in the active site cleft of
hMDH1. Experimentation with other substrates,
including pyruvate, hydroxypyruvate, and
phenylpyruvate, should be performed to further
assess the substrate recognition properties of the
mutant (14).
The Pro110Ser mutant of hMDH1 achieves
a higher turnover number with the endogenous
substrate, OAA. This occurs at the cost of
substrate specificity, however, as the specificity
constant for the WT is roughly two times that of
the mutant. Replacement of proline with serine
likely destabilizes the enzyme-substrate complex,
leading to a faster dissociation of OAA to malate.
To conclude, the WT enzyme differentiates
between OAA and AKG more effectively than
does the mutant. However, Pro110Ser hMDH1 is
more active than the WT with OAA. In addition,
the mutant enzyme is likely a better catalyst with
the alternative substrate, AKG, as indicated by the
reasonable kinetic constants (Table 2). Substrate
binding to the enzyme active site is essential for

mutant hMDH1 enzymes are 39.749 kDa and
39.739 kDa, respectively. The molecular weights
determined via standard curve analysis (Fig. 10)
were lower than the expected values. Increased
interactions between the respective protein and
sodium dodecyl sulfate (SDS) may have increased
the surrounding negative charge on the protein,
causing it to travel further down the gel (11). This
would explain the slightly lowered molecular
masses of the two enzymes.
The kinetics parameters of the WT and the
purified recombinant hMDH1 protein were
determined spectrophotometrically. Enzyme
activity, specificity, and proficiency were
evaluated. Values for kcat and kcat/KM (ksp) were
deemed the most useful parameters for quantitative
analysis of both enzymes (13). The kcat of the WT
enzyme with the endogenous substrate (OAA) was
320 ± 10 s-1 (Table 1). This number reflects values
reported in the literature (11, 12). The KM for the
WT enzyme with OAA was 18.4 ± 0.1 µM, and
the ksp was 1.7 ± 2 × 107 M-1s-1. By contrast, the
kcat of the mutant enzyme with OAA was 780 ± 30
s-1 (Table 2). The KM for the mutant enzyme with
OAA was 95.33 ± 0.07 µM, and the ksp was 8.21 ±
0.46 × 106 M-1s-1. The higher kcat of the mutant
with OAA indicates that more substrate molecules
were transformed into product per unit time by a
single mutant enzyme compared to the wildtype.
The higher ksp for the WT suggests that this
enzyme is more effective on OAA than is the
mutant. Loss of specificity for the native substrate
was expected for the mutant enzyme, as it was
hypothesized that Pro-110 is involved in substrate
recognition in the mobile active site loop. While
OAA binds more easily to the WT enzyme, it is
converted to malate at a slower rate. The higher
KM for the mutant enzyme suggests that the nature
of the enzyme-substrate complex (ES) was altered.
There was likely a higher activation energy barrier
for formation of the ES in the reaction scheme for
the mutant enzyme with OAA. Decreasing the
stability of the ES likely allowed for the malate
product to be released from the enzyme’s active
site sooner.
The activities of the WT and mutant
enzymes were assayed in the presence of the
alternative substrate, α-ketoglutarate (AKG). The
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catalysis. Mutation of Pro-110 decreases
specificity for OAA and confers greater turnover
with an alternative substrate, AKG. These studies
suggest that Pro-110 plays a role in the strict
substrate specificity of hMDH1. Experiments
aimed to reduce hMDH1 activity and likewise halt
glycolysis in proliferating cancer cells might look
to manipulate Pro-110.

enzyme mapping. A double digest was performed.
A virtual restriction enzyme digest was first run
with the enzymes XhoI and ClaI to determine the
expected fragment sizes. Benchling, a
bioinformatics platform, was used for this purpose.
The 50 µL restriction digest comprised CutSmart
NEB buffer (50 mM potassium acetate, 20 mM
Tris-acetate, 10 mM magnesium acetate, 100
µg/ml BSA, pH 7.9 at 25°C), 10 units each of
restriction enzymes XhoI and ClaI, and about 630
ng of DNA. The mixture was incubated at 37°C
for about 30 minutes. Once 10 µL of NEB gel
loading blue dye (2.5% Ficoll®-400, 11 mM
EDTA, 3.3 mM Tris-HCl, pH 8.0 at 25°C, 0.017%
SDS, and 0.015% bromophenol blue) were added
to 50 µL of restriction digest, the resulting mixture
was loaded onto a 1% agarose gel prepared with
SybrSafe in Tris-borate-EDTA (89 mM Tris, 89
mM boric acid, and 2 mM EDTA, pH 8.0). An
NEB Quick-Load Purple 1 kb plus DNA Ladder
was loaded onto the gel. The gel was placed on the
transilluminator for detection. The DNA bands
were analysed and compared to the virtual digest
to confirm the existence of the pET28a plasmid.

Experimental procedures
Bacterial culture
Escherichia coli BL21(DE3) cells
containing the protein production plasmid
(pET28a) that encodes the cytoplasmic human
malate dehydrogenase, hMDH1, were provided by
Jessica Bell (Department of Chemistry and
Biochemistry at the University of San Diego).
pET28a encodes isoform 3 of hMDH1. To harvest
large quantities of E. coli bacteria, liquid cultures
were started from a single colony on a streaked
plate. E. coli BL21(DE3) strains were grown in
Luria base (LB) medium at 28°C with shaking
(250 rpm). The LB medium was comprised of 1%
tryptone, 0.5% yeast extract and 1% NaCl. The
medium was supplemented with kanamycin at 50
μg/mL.

Site-directed mutagenesis: PCR
Site-directed mutagenesis was employed
for amino acid substitution. Specifically, a proline
amino acid residue located at position 110 in
hMDH1 isoform 3 was replaced with serine.
Mutagenic primers were used to PCR amplify the
plasmid expressing the hMDH1 gene (pET28a),
inducing a substitution mutation in the process.
The primers were designed using Benchling and
NEBase changer. The forward primer sequence
was GGGCTCCATGAGCAGAAGGGAAG, and
the reverse primer sequence was
ACAAGAATGGCCACATCC. The Q5 sitedirected mutagenesis kit prepared by New England
BioLabs (NEB) was used in the PCR. PCR was
performed in a total volume of 25 µL containing
0.5 µM of each primer, 25 ng of DNA, and Q5 hot
start high-fidelity Master Mix. The thermocycler
was programmed to 98°C for 30 seconds to initiate
denaturation. Next, 25 PCR cycles were completed
at 98°C for 10 seconds, 61°C for 30 seconds, and
72°C for 20 seconds. The final extension period
lasted 2 minutes at 72°C. DNA agarose gel

WT plasmid isolation
A plasmid miniprep was performed to
extract hMDH1 isoform 3 pET28a plasmid DNA
from E. coli BL21(DE3) cells. The procedure was
adapted from Zyppy Plasmid Miniprep Kit
instructions from Zymo Research (Irvine, CA).
hMDH1 pET28a cells (6 mL) were processed
according to the manufacturer’s instructions. The
column was eluted with 10 mM Tris-HCl, pH 8.5
and 0.1 mM EDTA. To increase DNA yield, the
elution buffer was pre-warmed to 50°C, and the
incubation period was increased to 20 minutes. A
NanoDrop spectrophotometer was used to assess
the purity of the plasmid DNA at absorbances of
260 nm and 280 nm. The DNA concentration was
also measured.
Plasmid DNA restriction analysis
After extracting hMDH1 isoform 3 pET28a
DNA, the DNA was analysed via restriction
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electrophoresis was conducted using a 0.8%
agarose gel with SybrSafe in Tris-borate-EDTA
(TBE). PCR samples were prepared for
electrophoresis by mixing 2 µL of NEB gel
loading blue dye with 10 µL of PCR reaction
mixture. An NEB Quick-Load Purple 1 kb DNA
Ladder was loaded onto the gel. The gel was
placed on the transilluminator for detection. The
band of the DNA was observed to determine the
size of the amplified fragment and to verify the
amplification of the template.

Research (Irvine, CA). Mutant hMDH1 pET28a
cells (3 mL) were processed according to the
manufacturer’s instructions, as described
previously. The DNA was resuspended in 30 µL of
water. The resulting substitution mutation was
verified by DNA sequencing with GeneWiz.

Bacterial transformation
The plasmid encoding the gene for the
genetically modified human cytosolic malate
dehydrogenase isoform 3 was introduced to XJb
(DE3) bacterial cells, prepared by Zymo Research
(Irvine, CA). Mutant hMDH1 plasmid DNA (144
Site-directed mutagenesis: transformation
ng) was added to 50 μL of Z-competent XJb (DE3)
A kinase, ligase, and Dpnl (KLD)
cells. Following a 10-minute incubation period,
treatment was completed to introduce the mutant
four volumes of room temperature SOC media
plasmid into competent NEB 5α E. coli cells. The
(208 μL) was added. The resulting mixture was
kinase phosphorylated the 5’ end of the plasmid
expressing the mutant hMDH1 gene (pET28a), and incubated for 1 hour at 37°C with gentle shaking
(150 rpm). The cells were spun down at 3,000 × g
the ligase sealed the nick to produce the
circularized plasmid. The restriction enzyme DpnI for 3 minutes. The supernatant was removed (150
digested the original template plasmid that did not µL), and the pellet was resuspended. Resuspended
cells (100 μL) were spread onto an LB and
contain the mutation. The reaction was performed
kanamycin plate. After about 15 minutes, the plate
in a total volume of 10 μL containing KLD
was inverted and incubated overnight at 37°C.
reaction buffer, KLD enzyme mix, and 25 ng of
hMHD1 mutant plasmid PCR product. The
WT hMDH1 isoform 3 protein overexpression
resulting solution was incubated at room
temperature for about 5 minutes. The KLD mixture
The bacterial transformation of XJb (DE3)
(5 μL) was added to 50 μL of thawed NEB 5α
bacterial cells was followed by overexpression, in
competent E. coli cells. The resulting mixture was which the wildtype (WT) hMDH1 isoform 3
placed on ice for about 40 minutes. The cells were plasmid gene was used by the host bacterium to
heat shocked at 42°C for 30 seconds and placed on transcribe mRNA, followed by translation into
ice for 5 minutes. Room temperature SOC media
protein. Liquid cultures were started from a single
(950 μL) was added to the mixture, which was
hMDH1 isoform 3 colony on a streaked plate. E.
incubated at 37°C for about 1 hour with shaking
coli XJb (DE3) strains, prepared by Zymo
(250 rpm). Onto one LB + kanamycin plate, 100
Research (Irvine, CA), were grown in Luria base
μL of cells were spread. The remaining cells were
(LB) medium at 37°C with shaking (250 rpm). The
centrifuged at 3,000 × g for 3 minutes. Virtually all media was supplemented with kanamycin at 50
of the supernatant was removed, and the pellet was μg/mL. The OD600 was between 4.0 and 5.0 at the
resuspended. Resuspended cells (100 μL) were
final stationary growth phase. The starter culture
spread onto another LB + kanaycin plate. Both
was expanded by adding 1 mL to 50-mL of LB
plates were incubated overnight at 37°C.
and kanamycin in a 250-mL baffled flask. The
culture was then incubated for 2 hours at 37°C
until the density reached an OD600 of about 0.55Mutant plasmid miniprep
0.6. Once the appropriate OD was reached, cells
A plasmid miniprep was performed to
were cooled to room temperature, followed by
extract the potential mutant plasmid hMDH1
induction with IPTG to a final concentration of 0.5
isoform 3 pET28a plasmid DNA from NEB 5α E.
coli cells. The procedure was adapted from Zyppy mM. Arabinose was also added to a final
concentration of 3 mM. Cells were grown
Plasmid Miniprep Kit instructions from Zymo
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overnight with vigorous shaking (250 rpm) at
20°C. Cells were harvested the following day by
centrifugation at 3,000 × g for 10 minutes at 10 ˚C.
Since a freeze-thaw cycle is critical to cell lysis,
cells were frozen at −20 °C in advance of lysis.

absorbance at 280 nm reached 0.1. The bound WT
hMDH1 protein was eluted with two resin-bed
volumes (4 mL) of PBS containing 250 mM
imidazole. The absorbance was again measured at
280 nm. The mutant hMDH1 isoform 3 protein
was purified the same way, only cell lysate
containing the mutant was used.

Cell lysis with WT and mutant protein
Cells overexpressing the WT hMDH1
isoform 3 protein were lysed to obtain a lysate that
could be used to purify the protein by nickel
affinity (Ni-NTA) chromatography. Cells were
removed from the −20°C freezer and thawed on
ice. Cells were resuspended in approximately 3
mL/g cell pellet of lysis buffer (20 mM Tris, 100
mM NaCl, pH 8.0) to which a cocktail of protease
inhibitors was added. One tablet of Pierce protease
inhibitor mini-tablets was dissolved per 10 mL of
lysis buffer. The pellet was resuspended. To
expedite the cell lysis process, lysozyme was
added to a final concentration of 50 µg/mL.
DNAse I (60 units) was also added. The resulting
mixture was incubated for 30 minutes at 37°C with
shaking (200 rpm). The sample was centrifuged at
21,130 × g for 5 minutes at 4°C. The supernatant
was removed and centrifuged at 21,130 × g for 15
minutes at 4°C. Cells overexpressing the mutant
hMDH1 isoform 3 protein were lysed in the same
manner in order to obtain a lysate that could be
used to purify the protein by Ni-NTA
chromatography.

BCA assay
A bicinchoninic (BCA) assay was
performed to determine the protein concentrations
of the WT and mutant hMDH1 (15). A BCA assay
kit from Pierce Chemical Company (Pierce,
Product #23209) was used. The instructions were
followed exactly, only the sample and working
reagent volumes were halved. In addition, the
working reagent was prepared in a 50:2 ratio of
reagent A to reagent B.
SDS-PAGE
SDS-PAGE was performed to determine
the molecular weight of both the WT and the
mutant hMDH1 proteins and to assess the success
of the BCA purification procedure. The methods of
Laemmli were followed with minor changes (16).
A 12% separating gel was prepared. A 4%
stacking gel was prepared. The sample buffer was
comprised of 31.25 mM Tris (pH 6.8), 1% SDS,
12.5% glycerol, 0.005% bromophenol blue, 2.5%
β-mercaptoethanol. The protein samples were
immersed in boiling water for 30 minutes.
Electrophoresis was carried out at 200 V for 45
minutes. The completed gel was stained overnight
in Coomassie Blue stain staining solution
containing 0.025% Coomassie Blue R-250, 40%
methanol, and 7% acetic acid. The stained gel was
then destained in a solution consisting of 40%
methanol, 7% acetic acid, and 3% glycerol.

WT and mutant protein purification
Nickel affinity chromatography was
employed to purify the WT hMDH1 isoform 3
protein. Clarified cell lysate from an expression
culture was used in this experiment. A variation of
the batch method listed in ThermoScientific’s
protocol for the HisPur Ni-NTA resin (Catalog
#88221) was used. The total volume of settled
resin was 2 mL. The resin was equilibrated in two
resin-bed volumes of equilibration buffer (PBS, 20
mM sodium phosphate, 300 mM sodium chloride,
pH 8). The entire cell lysate containing the WT
hMDH1 isoform 3 protein was added to the resin
and mixed on an end-over-end rotator for 15
minutes at 4°C. The flow-through was then
collected. The column was washed with wash
buffer (PBS with 25 mM imidazole) until the

Enzyme kinetics
Several kinetics experiments were
performed to assess the activities of both the WT
and the mutant hMDH1 proteins in the presence of
the native substrate, oxaloacetate (OAA), and an
alternative substrate, α-ketoglutarate (AKG). The
reaction catalyzed by MDH, namely the
conversion of malate to oxaloacetate, was run in
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reverse. Consumption of NADH over time was
monitored spectrophotometrically. A routine WT
hMDH1 assay with OAA and NADH was first
performed. The Cary-50 UV-Vis
Spectrophotometer was zeroed at 340 nm. The
assay was conducted with variable OAA
concentrations (5−315 µM), a constant NADH
concentration of 0.166 mM, and 99.2 mM
potassium phosphate buffer (pH 8). The WT
hMDH1 enzyme concentration was 1.03 nM. The
oxidation of NADH was observed by measuring
the decrease in absorbance at 340 nm. The assay
was linear for one minute. The NADH solution
was kept at room temperature throughout the assay
and the substrate solutions were kept on ice. The
assay was performed identically for the WT
enzyme with the alternative substrate, αketoglutarate (AKG), only the 3,000 µL reaction
mixture comprised 513 nM of enzyme, 0.149 mM
NADH, 90.0 mM potassium phosphate buffer (pH
8), and a range of AKG concentrations from 4.8 to
3,000 µM. The kinetics of the mutant enzyme were
also studied. For the experiment with OAA, the
3,000 µL reaction mixture was comprised of 3.5
nM of the mutant hMDH1 protein, 0.166 mM
NADH, 98.7 mM potassium phosphate buffer (pH
8), and an OAA concentration range from 4.8 to
300 µM. Finally, for the mutant enzyme with
AKG, the 3,000 µL reaction mixture was
comprised of 369 nM mutant hMDH1, 0.149 mM
NADH, 90.0 mM potassium phosphate buffer (pH
8), and OAA ranging in concentration from 480 to
3,000 µM.
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